These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31128886)

  • 21. Patatin-like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages.
    Mangge H; Baumgartner BG; Zelzer S; Prüller F; Schnedl WJ; Reininghaus EZ; Haybaeck J; Lackner C; Stauber R; Aigner E; Weghuber D
    Aliment Pharmacol Ther; 2015 Jul; 42(1):99-105. PubMed ID: 25939720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease.
    Aller R; Laserna C; Rojo MÁ; Mora N; García Sánchez C; Pina M; Sigüenza R; Durà M; Primo D; Izaola O; de Luis D
    Rev Esp Enferm Dig; 2018 Oct; 110(10):634-640. PubMed ID: 30032630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
    Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
    Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal and lifestyle factors mediate the association between maternal education and preschool children's weight status: the ToyBox study.
    Androutsos O; Moschonis G; Ierodiakonou D; Karatzi K; De Bourdeaudhuij I; Iotova V; Zych K; Moreno LA; Koletzko B; Manios Y;
    Nutrition; 2018 Apr; 48():6-12. PubMed ID: 29469021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.
    Jiang ZG; Tapper EB; Kim M; Connelly MA; Krawczyk SA; Yee EU; Herman MA; Mukamal KJ; Lai M
    J Clin Gastroenterol; 2018; 52(5):444-451. PubMed ID: 28362682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients.
    Vespasiani-Gentilucci U; Gallo P; Porcari A; Carotti S; Galati G; Piccioni L; De Vincentis A; Dell'Unto C; Vorini F; Morini S; Riva E; Picardi A
    Scand J Gastroenterol; 2016 Aug; 51(8):967-73. PubMed ID: 27150500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease.
    Miyaaki H; Nakao K
    Clin J Gastroenterol; 2017 Jun; 10(3):201-207. PubMed ID: 28290069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L; Al-Serri A; Daly AK; Galmozzi E; Rametta R; Dongiovanni P; Nobili V; Mozzi E; Roviaro G; Vanni E; Bugianesi E; Maggioni M; Fracanzani AL; Fargion S; Day CP
    Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human germline hedgehog pathway mutations predispose to fatty liver.
    Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
    J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease.
    Lombardi R; Iuculano F; Pallini G; Fargion S; Fracanzani AL
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease.
    Kong L; Lu Y; Zhang S; Nan Y; Qiao L
    Discov Med; 2017 Sep; 24(131):95-106. PubMed ID: 28972878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
    Mosca A; Fintini D; Scorletti E; Cappa M; Paone L; Zicari AM; Nobili V; Byrne CD
    Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study.
    Uygun A; Ozturk K; Demirci H; Oztuna A; Eren F; Kozan S; Yilmaz Y; Kurt O; Turker T; Vatansever S; Alper E; Unsal B
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):441-447. PubMed ID: 28253210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L; Alisi A; Galmozzi E; Bartuli A; Del Menico B; Alterio A; Dongiovanni P; Fargion S; Nobili V
    Hepatology; 2010 Oct; 52(4):1274-80. PubMed ID: 20648474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).
    Mehta R; Jeiran K; Koenig AB; Otgonsuren M; Goodman Z; Baranova A; Younossi Z
    BMC Med Genet; 2016 Sep; 17(1):63. PubMed ID: 27596100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease.
    Nobili V; Donati B; Panera N; Vongsakulyanon A; Alisi A; Dallapiccola B; Valenti L
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):632-6. PubMed ID: 24345846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and course of diabetes according to genetic factors and diabetes treatment among patients with nonalcoholic fatty liver disease.
    Kogiso T; Sagawa T; Kodama K; Taniai M; Hashimoto E; Tokushige K
    Nutrition; 2021 Mar; 83():111080. PubMed ID: 33348109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Hepatology; 2011 Jun; 53(6):1883-94. PubMed ID: 21381068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.